Impact of diabetes on left ventricular diastolic function in patients with arterial hypertension

Rolf Wachter1, Claus Lüers, Sibylle Kleta

  • 1Department of Cardiology and Pneumology, University of Göttingen, Robert-Koch-Str. 40, 37075 Göttingen, Germany.

Insights

Diabetes mellitus negatively impacts diastolic function in hypertensive patients, particularly in men. This finding highlights the importance of managing diabetes to preserve heart health in this population.

Area of Science:

  • Cardiology
  • Endocrinology
  • Hypertension Research

Background:

  • Arterial hypertension is a significant risk factor for cardiovascular disease.
  • Diabetes mellitus is increasingly prevalent and exacerbates cardiovascular complications.
  • Diastolic dysfunction is an early indicator of cardiac impairment.

Purpose of the Study:

  • To investigate the impact of diabetes mellitus on diastolic function in patients with hypertension.
  • To identify specific echocardiographic parameters affected by diabetes in hypertensive individuals.
  • To explore sex-specific differences in the effect of diabetes on diastolic function.

Main Methods:

  • Echocardiographic evaluation of systolic and diastolic function in 439 hypertensive patients.
  • Analysis of overall diastolic function and specific parameters like the E/Ea ratio.
  • Comparison of diastolic function between diabetic (DM(+)) and non-diabetic (DM(-)) subgroups.

Main Results:

  • Lower prevalence of normal diastolic function in DM(+) patients (19.4% vs. 30.8%).
  • Higher rates of moderate/severe diastolic dysfunction in DM(+) patients (15.3% vs. 9.2%, p=0.022).
  • Significantly higher E/Ea ratio in DM(+) patients (12.3+/-4.4 vs. 10.8+/-3.6, p<0.001), with effects predominantly in males.

Conclusions:

  • Diabetes mellitus adversely affects diastolic function in hypertensive patients.
  • The detrimental effect of diabetes on diastolic function is primarily observed in the male subgroup.
  • Managing diabetes is crucial for preventing or mitigating diastolic dysfunction in hypertensive individuals.
Abstract

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...